Menarini’s international network grows with new South African subsidiary

Menarini Group expanded its presence in Africa by opening a new headquarters in Cape Town in March 2024 and commenced full operations on January 1, 2025, after receiving registration certificates from the Healthcare Authority (SAHPRA), Department of Health (DOH), and the South African Pharmacy Council (SAPC). While the Florence-based pharmaceutical company has long collaborated with South African partners, this direct presence strengthens its foothold in one of Africa’s most significant pharmaceutical markets.

The team spearheads several initiatives to broaden the company’s product portfolio and bring new treatments to South African patients over the coming years. Regional Head of Africa Attilio Di Gaudio and Country Manager Nico Bosch shared their vision about the expansion.

Our partnerships in South Africa have served us well for years”, Di Gaudio explained. “By establishing our headquarters and building our team here, we’re gaining the autonomy needed to grow in this market, following Menarini’s successful approach in other key regions. With regulatory requirements and audits completed before the end of 2024, we’re now focused on establishing and entrenching Menarini and our portfolio to become a trusted partner of choice.”

South Africa has a young, but aging population and quality healthcare for all citizens remains one of the biggest priorities of our government”, Bosch explained. Menarini is proud to bring new quality medication to South Africa to help improve patient outcomes. In addition, we positively contribute to the economy, with a focus on allowing young graduates to develop careers within the healthcare industry. Our ambition is to become a trusted partner of choice, with patients being at the centre of everything we do, to continue to build on the global success of Menarini.

The South African subsidiary will initially concentrate on cardiovascular, respiratory, and pain management therapies, with plans to branch into other therapeutic areas.

As part of the launch, the Menarini team is undergoing comprehensive training for their work with healthcare professionals, to ensure alignment with Menarini’s high standards.